MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia
August 07, 2026
August 07, 2026
MEMPHIS, Tennessee, Aug. 7 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia
*
Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangemen . . .
* * *
MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia
*
Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangemen . . .